NO322709B1 - Nye indenoindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents
Nye indenoindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem Download PDFInfo
- Publication number
- NO322709B1 NO322709B1 NO20022794A NO20022794A NO322709B1 NO 322709 B1 NO322709 B1 NO 322709B1 NO 20022794 A NO20022794 A NO 20022794A NO 20022794 A NO20022794 A NO 20022794A NO 322709 B1 NO322709 B1 NO 322709B1
- Authority
- NO
- Norway
- Prior art keywords
- group
- compound
- branched
- formula
- linear
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 191
- 238000000034 method Methods 0.000 title claims description 130
- 238000002360 preparation method Methods 0.000 title claims description 26
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 7
- -1 biphenylyl Chemical group 0.000 claims description 69
- 150000002923 oximes Chemical class 0.000 claims description 39
- 125000000217 alkyl group Chemical group 0.000 claims description 27
- 150000003839 salts Chemical class 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 17
- 229910052757 nitrogen Inorganic materials 0.000 claims description 16
- 125000003118 aryl group Chemical group 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 8
- 125000005842 heteroatom Chemical group 0.000 claims description 8
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 7
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 4
- 125000005530 alkylenedioxy group Chemical group 0.000 claims description 4
- 125000004429 atom Chemical group 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 3
- 239000002246 antineoplastic agent Substances 0.000 claims description 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 2
- 125000003635 2-dimethylaminoethoxy group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])O* 0.000 claims description 2
- 239000005864 Sulphur Substances 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 125000004423 acyloxy group Chemical group 0.000 claims description 2
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 2
- 125000002619 bicyclic group Chemical group 0.000 claims description 2
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000002950 monocyclic group Chemical group 0.000 claims description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 2
- 125000006684 polyhaloalkyl group Polymers 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 229910052717 sulfur Chemical group 0.000 claims description 2
- 239000011593 sulfur Chemical group 0.000 claims description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 2
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 claims description 2
- LSXXOBXVFRXXIU-RFBIWTDZSA-N 2-[[(10Z)-10-but-3-yn-2-yloxyimino-2,3-dimethoxy-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine Chemical compound C1=C(OCCN(C)C)C=C2C(C(=N\OC(C)C#C)/C=3C=C(C(=CC=33)OC)OC)=C3NC2=C1 LSXXOBXVFRXXIU-RFBIWTDZSA-N 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000000047 product Substances 0.000 description 139
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 82
- 238000002844 melting Methods 0.000 description 71
- 230000008018 melting Effects 0.000 description 71
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 13
- 239000000203 mixture Substances 0.000 description 10
- XLYPHUGUKGMURE-UHFFFAOYSA-N 5-hydroxy-2-nitrobenzaldehyde Chemical compound OC1=CC=C([N+]([O-])=O)C(C=O)=C1 XLYPHUGUKGMURE-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 230000000259 anti-tumor effect Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- LJKJXQLWGBIHIU-UHFFFAOYSA-N o-(1-phenylprop-2-ynyl)hydroxylamine;hydrochloride Chemical compound Cl.NOC(C#C)C1=CC=CC=C1 LJKJXQLWGBIHIU-UHFFFAOYSA-N 0.000 description 6
- CEFBXYRCGUITCZ-UHFFFAOYSA-N o-prop-2-ynylhydroxylamine;hydrochloride Chemical compound Cl.NOCC#C CEFBXYRCGUITCZ-UHFFFAOYSA-N 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- NRXXPMKETMJSSI-UHFFFAOYSA-N o-but-3-yn-2-ylhydroxylamine;hydrochloride Chemical compound Cl.NOC(C)C#C NRXXPMKETMJSSI-UHFFFAOYSA-N 0.000 description 5
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- XIQUJVRFXPBMHS-UHFFFAOYSA-N hydron;o-prop-2-enylhydroxylamine;chloride Chemical compound Cl.NOCC=C XIQUJVRFXPBMHS-UHFFFAOYSA-N 0.000 description 4
- 231100000682 maximum tolerated dose Toxicity 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 description 2
- ZKMKYPLJOVPKRF-JOTHOCIUSA-N 2-[[(10E)-1,4-dimethoxy-10-phenylmethoxyimino-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine hydrochloride Chemical compound Cl.C1=2C(OC)=CC=C(OC)C=2C=2NC3=CC=C(OCCN(C)C)C=C3C=2\C1=N/OCC1=CC=CC=C1 ZKMKYPLJOVPKRF-JOTHOCIUSA-N 0.000 description 2
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 description 2
- LQLJZSJKRYTKTP-UHFFFAOYSA-N 2-dimethylaminoethyl chloride hydrochloride Chemical compound Cl.CN(C)CCCl LQLJZSJKRYTKTP-UHFFFAOYSA-N 0.000 description 2
- FJPMLTZXTKBVKX-UHFFFAOYSA-N 4,6-Dimethoxy-phthalide Chemical compound COC1=CC(OC)=CC2=C1COC2=O FJPMLTZXTKBVKX-UHFFFAOYSA-N 0.000 description 2
- ABFJCCZUMNBAAI-UHFFFAOYSA-N 4,7-dimethoxy-3h-2-benzofuran-1-one Chemical compound COC1=CC=C(OC)C2=C1COC2=O ABFJCCZUMNBAAI-UHFFFAOYSA-N 0.000 description 2
- ODHPXVGFARBBSK-UHFFFAOYSA-N 5,7-dimethoxy-3h-2-benzofuran-1-one Chemical compound COC1=CC(OC)=CC2=C1C(=O)OC2 ODHPXVGFARBBSK-UHFFFAOYSA-N 0.000 description 2
- BNTDDWPHSMILHQ-UHFFFAOYSA-N 5-methoxy-2-nitrobenzaldehyde Chemical compound COC1=CC=C([N+]([O-])=O)C(C=O)=C1 BNTDDWPHSMILHQ-UHFFFAOYSA-N 0.000 description 2
- NHOZLQCFHOVMLW-UHFFFAOYSA-N 5h-indeno[1,2-b]indol-10-one Chemical compound N1C2=CC=CC=C2C2=C1C1=CC=CC=C1C2=O NHOZLQCFHOVMLW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004452 microanalysis Methods 0.000 description 2
- HDPKLKMNNDGHLC-UHFFFAOYSA-N o-(1-cyclopropylprop-2-ynyl)hydroxylamine;hydrochloride Chemical compound Cl.NOC(C#C)C1CC1 HDPKLKMNNDGHLC-UHFFFAOYSA-N 0.000 description 2
- XLFJVRPMJOHGLH-UHFFFAOYSA-N o-(1-phenylbut-2-ynyl)hydroxylamine;hydrochloride Chemical compound Cl.CC#CC(ON)C1=CC=CC=C1 XLFJVRPMJOHGLH-UHFFFAOYSA-N 0.000 description 2
- LWTQNCDTQLWMOU-UHFFFAOYSA-N o-[1-(furan-3-yl)prop-2-ynyl]hydroxylamine;hydrochloride Chemical compound Cl.NOC(C#C)C=1C=COC=1 LWTQNCDTQLWMOU-UHFFFAOYSA-N 0.000 description 2
- FRNGIUXKDJKDSJ-UHFFFAOYSA-N o-[2-(dimethylamino)ethyl]hydroxylamine;hydrochloride Chemical compound Cl.CN(C)CCON FRNGIUXKDJKDSJ-UHFFFAOYSA-N 0.000 description 2
- HYDZPXNVHXJHBG-UHFFFAOYSA-N o-benzylhydroxylamine;hydron;chloride Chemical compound Cl.NOCC1=CC=CC=C1 HYDZPXNVHXJHBG-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 125000001113 thiadiazolyl group Chemical group 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- ABZKNVCKNIUXSR-SGEDCAFJSA-N (10z)-2,3-dimethoxy-5-methyl-10-(1-phenylprop-2-ynoxyimino)indeno[1,2-b]indol-8-ol Chemical compound CN1C2=CC=C(O)C=C2C2=C1C=1C=C(OC)C(OC)=CC=1\C2=N\OC(C#C)C1=CC=CC=C1 ABZKNVCKNIUXSR-SGEDCAFJSA-N 0.000 description 1
- FQHCPFMTXFJZJS-UHFFFAOYSA-N (4-methoxyphenyl)hydrazine;hydrochloride Chemical compound Cl.COC1=CC=C(NN)C=C1 FQHCPFMTXFJZJS-UHFFFAOYSA-N 0.000 description 1
- LACMZHMOICUKGN-UHFFFAOYSA-M (5,6-diethoxy-3-oxo-1h-2-benzofuran-1-yl)-triphenylphosphanium;bromide Chemical compound [Br-].O1C(=O)C=2C=C(OCC)C(OCC)=CC=2C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 LACMZHMOICUKGN-UHFFFAOYSA-M 0.000 description 1
- AIFAWXWFXVGQRW-UHFFFAOYSA-M (5,6-dimethoxy-3-oxo-1h-2-benzofuran-1-yl)-triphenylphosphanium;bromide Chemical compound [Br-].O1C(=O)C=2C=C(OC)C(OC)=CC=2C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 AIFAWXWFXVGQRW-UHFFFAOYSA-M 0.000 description 1
- OTZXKUICIHQPQD-VZXGSGAOSA-N (NZ)-N-[8-[2-(dimethylamino)ethoxy]-2,3-dimethoxy-5H-indeno[1,2-b]indol-10-ylidene]hydroxylamine hydrochloride Chemical compound Cl.C1=C(OCCN(C)C)C=C2C(C(=N\O)/C=3C=C(C(=CC=33)OC)OC)=C3NC2=C1 OTZXKUICIHQPQD-VZXGSGAOSA-N 0.000 description 1
- LNZYHIITQXDLFY-OHYPFYFLSA-N (Z)-2,3,8-trimethoxy-N-(1-phenylprop-2-ynoxy)-5H-indeno[1,2-b]indol-10-imine Chemical compound C1=2C3=CC(OC)=CC=C3NC=2C2=CC(OC)=C(OC)C=C2\C1=N\OC(C#C)C1=CC=CC=C1 LNZYHIITQXDLFY-OHYPFYFLSA-N 0.000 description 1
- PLJSFLAPGQRMCU-OHYPFYFLSA-N (z)-2,3,8-trimethoxy-5-methyl-n-(1-phenylprop-2-ynoxy)indeno[1,2-b]indol-10-imine Chemical compound C1=2C3=CC(OC)=CC=C3N(C)C=2C2=CC(OC)=C(OC)C=C2\C1=N\OC(C#C)C1=CC=CC=C1 PLJSFLAPGQRMCU-OHYPFYFLSA-N 0.000 description 1
- VFLQQZCRHPIGJU-UHFFFAOYSA-N 1-(2-chloroethyl)piperidine;hydron;chloride Chemical compound Cl.ClCCN1CCCCC1 VFLQQZCRHPIGJU-UHFFFAOYSA-N 0.000 description 1
- RMGFLMXDCGQKPS-UHFFFAOYSA-N 1-(2-chloroethyl)pyrrolidine Chemical compound ClCCN1CCCC1 RMGFLMXDCGQKPS-UHFFFAOYSA-N 0.000 description 1
- VZWIQRAVCKIZRS-UHFFFAOYSA-N 1-chloro-1-ethynylcyclopentane Chemical compound C#CC1(Cl)CCCC1 VZWIQRAVCKIZRS-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- VGSZCLXUVDJMEN-UHFFFAOYSA-N 2,3,8-trimethoxy-5h-indeno[1,2-b]indol-10-one;hydrochloride Chemical compound Cl.C12=CC(OC)=C(OC)C=C2C(=O)C2=C1NC1=CC=C(OC)C=C12 VGSZCLXUVDJMEN-UHFFFAOYSA-N 0.000 description 1
- KHVHHKNFFYUOMU-UHFFFAOYSA-N 2,3-dimethoxy-5-methyl-8-(2-piperidin-1-ylethoxy)indeno[1,2-b]indol-10-one Chemical compound C1=2C=C(OC)C(OC)=CC=2C(=O)C(C2=C3)=C1N(C)C2=CC=C3OCCN1CCCCC1 KHVHHKNFFYUOMU-UHFFFAOYSA-N 0.000 description 1
- NYRREOIMJTVMCI-UHFFFAOYSA-N 2,3-dimethoxy-5h-indeno[1,2-b]indol-10-one;hydrochloride Chemical compound Cl.C1=CC=C2C(C(=O)C=3C=C(C(=CC=33)OC)OC)=C3NC2=C1 NYRREOIMJTVMCI-UHFFFAOYSA-N 0.000 description 1
- IOPFUSMCYUKKEA-UHFFFAOYSA-N 2,3-dimethoxy-8-(2-piperidin-1-ylethoxy)-5h-indeno[1,2-b]indol-10-one;hydrochloride Chemical compound Cl.C1=2C=C(OC)C(OC)=CC=2C(=O)C(C2=C3)=C1NC2=CC=C3OCCN1CCCCC1 IOPFUSMCYUKKEA-UHFFFAOYSA-N 0.000 description 1
- MCGRHMJQSBGSLL-UHFFFAOYSA-N 2,3-dimethoxy-8-(2-pyrrolidin-1-ylethoxy)-5h-indeno[1,2-b]indol-10-one;hydrochloride Chemical compound Cl.C1=2C=C(OC)C(OC)=CC=2C(=O)C(C2=C3)=C1NC2=CC=C3OCCN1CCCC1 MCGRHMJQSBGSLL-UHFFFAOYSA-N 0.000 description 1
- VCNFHHJIIASDOQ-QIRPVNSRSA-N 2-[(10z)-10-[1-(furan-3-yl)prop-2-ynoxyimino]-2,3-dimethoxy-5-methylindeno[1,2-b]indol-8-yl]oxy-n,n-dimethylethanamine;hydrochloride Chemical compound Cl.CN1C2=CC=C(OCCN(C)C)C=C2C2=C1C=1C=C(OC)C(OC)=CC=1\C2=N\OC(C#C)C=1C=COC=1 VCNFHHJIIASDOQ-QIRPVNSRSA-N 0.000 description 1
- ZYGLYAZYIZBURJ-VZXGSGAOSA-N 2-[(Z)-(2,3-dimethoxy-5H-indeno[1,2-b]indol-10-ylidene)amino]oxy-N,N-dimethylethanamine hydrochloride Chemical compound Cl.C1=CC=C2C(C(=N\OCCN(C)C)/C=3C=C(C(=CC=33)OC)OC)=C3NC2=C1 ZYGLYAZYIZBURJ-VZXGSGAOSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- SREKSSNRKXSTAR-QULZXSILSA-N 2-[[(10Z)-10-[(1R)-1-cyclopropylprop-2-ynoxy]imino-2,3-dimethoxy-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine hydrochloride Chemical compound Cl.C1([C@H](C#C)O/N=C2/C=3C=C(C(=CC=3C3=C2C2=CC(OCCN(C)C)=CC=C2N3)OC)OC)CC1 SREKSSNRKXSTAR-QULZXSILSA-N 0.000 description 1
- SFSDOHVWGOZPPU-QIRPVNSRSA-N 2-[[(10Z)-10-[1-(furan-3-yl)prop-2-ynoxyimino]-2,3-dimethoxy-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine hydrochloride Chemical compound Cl.N1C2=CC=C(OCCN(C)C)C=C2C2=C1C=1C=C(OC)C(OC)=CC=1\C2=N\OC(C#C)C=1C=COC=1 SFSDOHVWGOZPPU-QIRPVNSRSA-N 0.000 description 1
- CCOIOFSSIHFRAA-WZRSSYQVSA-N 2-[[(10Z)-10-but-2-ynoxyimino-2,3-dimethoxy-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine hydrochloride Chemical compound Cl.C1=C(OCCN(C)C)C=C2C(C(=N\OCC#CC)/C=3C=C(C(=CC=33)OC)OC)=C3NC2=C1 CCOIOFSSIHFRAA-WZRSSYQVSA-N 0.000 description 1
- QPNUAWJNIKBOCH-ADYMNVQMSA-N 2-[[(10Z)-10-but-3-yn-2-yloxyimino-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine hydrochloride Chemical compound Cl.N1C2=CC=C(OCCN(C)C)C=C2C2=C1C1=CC=CC=C1/C2=N/OC(C)C#C QPNUAWJNIKBOCH-ADYMNVQMSA-N 0.000 description 1
- WNFCOAOXQHYZLM-GWLNUVCFSA-N 2-[[(10Z)-2,3-diethoxy-10-[1-(furan-3-yl)prop-2-ynoxyimino]-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine hydrochloride Chemical compound Cl.N1C2=CC=C(OCCN(C)C)C=C2C2=C1C=1C=C(OCC)C(OCC)=CC=1\C2=N\OC(C#C)C=1C=COC=1 WNFCOAOXQHYZLM-GWLNUVCFSA-N 0.000 description 1
- JKXVTYRKQVEVCI-YJKCNMNRSA-N 2-[[(10Z)-2,3-dimethoxy-10-(naphthalen-1-ylmethoxyimino)-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine Chemical compound C1=C(OCCN(C)C)C=C2C(C(=N\OCC=3C4=CC=CC=C4C=CC=3)/C=3C=C(C(=CC=33)OC)OC)=C3NC2=C1 JKXVTYRKQVEVCI-YJKCNMNRSA-N 0.000 description 1
- YTQOJJFMBQOBHR-YCNYHXFESA-N 2-[[(10Z)-2,3-dimethoxy-10-[(4-methoxyphenyl)methoxyimino]-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine Chemical compound C1=CC(OC)=CC=C1CO\N=C\1C(C2=CC(OCCN(C)C)=CC=C2N2)=C2C2=CC(OC)=C(OC)C=C2/1 YTQOJJFMBQOBHR-YCNYHXFESA-N 0.000 description 1
- JYDFYFDIJLHRLQ-ZSWXBHCYSA-N 2-[[(10Z)-2,3-dimethoxy-10-[(4-phenoxyphenyl)methoxyimino]-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine Chemical compound N1C2=CC=C(OCCN(C)C)C=C2C2=C1C=1C=C(OC)C(OC)=CC=1\C2=N\OCC(C=C1)=CC=C1OC1=CC=CC=C1 JYDFYFDIJLHRLQ-ZSWXBHCYSA-N 0.000 description 1
- AUDUEEPPVNPIRU-WKKHQKTCSA-N 2-[[(10Z)-2,3-dimethoxy-10-methoxyimino-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine hydrochloride Chemical compound Cl.N1C2=CC=C(OCCN(C)C)C=C2C2=C1C1=CC(OC)=C(OC)C=C1/C2=N/OC AUDUEEPPVNPIRU-WKKHQKTCSA-N 0.000 description 1
- YXQKRVAQTCSXDJ-QVLVYXDLSA-N 2-[[(10Z)-2,3-dimethoxy-10-pent-1-yn-3-yloxyimino-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine hydrochloride Chemical compound Cl.N1C2=CC=C(OCCN(C)C)C=C2C2=C1C1=CC(OC)=C(OC)C=C1/C2=N/OC(CC)C#C YXQKRVAQTCSXDJ-QVLVYXDLSA-N 0.000 description 1
- BINCJJQQLZUHNN-HYOGKJQXSA-N 2-[[(10Z)-2,3-dimethoxy-10-phenylmethoxyimino-5H-indeno[1,2-b]indol-8-yl]oxy]-N,N-dimethylethanamine Chemical compound N1C2=CC=C(OCCN(C)C)C=C2C2=C1C=1C=C(OC)C(OC)=CC=1\C2=N\OCC1=CC=CC=C1 BINCJJQQLZUHNN-HYOGKJQXSA-N 0.000 description 1
- CRJFDXQOAUUWQE-QIRPVNSRSA-N 2-[[(11Z)-11-[1-(furan-3-yl)prop-2-ynoxyimino]-15,18-dioxa-3-azapentacyclo[10.8.0.02,10.04,9.014,19]icosa-1(20),2(10),4(9),5,7,12,14(19)-heptaen-7-yl]oxy]-N,N-dimethylethanamine hydrochloride Chemical compound Cl.C1=2C3=CC(OCCN(C)C)=CC=C3NC=2C2=CC=3OCCOC=3C=C2\C1=N\OC(C#C)C=1C=COC=1 CRJFDXQOAUUWQE-QIRPVNSRSA-N 0.000 description 1
- XAPPBYYNDUPKMW-UHFFFAOYSA-N 2-aminooxyacetonitrile;hydrochloride Chemical compound Cl.NOCC#N XAPPBYYNDUPKMW-UHFFFAOYSA-N 0.000 description 1
- RAGSWDIQBBZLLL-UHFFFAOYSA-N 2-chloroethyl(diethyl)azanium;chloride Chemical compound Cl.CCN(CC)CCCl RAGSWDIQBBZLLL-UHFFFAOYSA-N 0.000 description 1
- WQMAANNAZKNUDL-UHFFFAOYSA-N 2-dimethylaminoethyl chloride Chemical compound CN(C)CCCl WQMAANNAZKNUDL-UHFFFAOYSA-N 0.000 description 1
- SJNVDRMYNJDFHS-UHFFFAOYSA-N 2-nitro-5-(2-piperidin-1-ylethoxy)benzaldehyde Chemical compound C1=C(C=O)C([N+](=O)[O-])=CC=C1OCCN1CCCCC1 SJNVDRMYNJDFHS-UHFFFAOYSA-N 0.000 description 1
- LGQHNVLFBLMLMI-UHFFFAOYSA-N 2-nitro-5-(2-pyrrolidin-1-ylethoxy)benzaldehyde Chemical compound C1=C(C=O)C([N+](=O)[O-])=CC=C1OCCN1CCCC1 LGQHNVLFBLMLMI-UHFFFAOYSA-N 0.000 description 1
- CMWKITSNTDAEDT-UHFFFAOYSA-N 2-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1C=O CMWKITSNTDAEDT-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- CRNIEXJWYHGTGR-UHFFFAOYSA-N 3-bromo-5,6-dimethoxy-3h-2-benzofuran-1-one Chemical compound C1=C(OC)C(OC)=CC2=C1C(=O)OC2Br CRNIEXJWYHGTGR-UHFFFAOYSA-N 0.000 description 1
- QSILYWCNPOLKPN-UHFFFAOYSA-N 3-chloro-3-methylbut-1-yne Chemical compound CC(C)(Cl)C#C QSILYWCNPOLKPN-UHFFFAOYSA-N 0.000 description 1
- WTNNDYSRQSOJKB-UHFFFAOYSA-N 3-chloro-3-methylpent-1-yne Chemical compound CCC(C)(Cl)C#C WTNNDYSRQSOJKB-UHFFFAOYSA-N 0.000 description 1
- XGSTZLKGNYGAMW-UHFFFAOYSA-N 5,6-diethoxy-3h-2-benzofuran-1-one Chemical compound C1=C(OCC)C(OCC)=CC2=C1C(=O)OC2 XGSTZLKGNYGAMW-UHFFFAOYSA-N 0.000 description 1
- UKFAWRZYFYOXEG-UHFFFAOYSA-N 5,6-dimethoxy-3H-isobenzofuran-1-one Chemical compound C1=C(OC)C(OC)=CC2=C1C(=O)OC2 UKFAWRZYFYOXEG-UHFFFAOYSA-N 0.000 description 1
- FUNZYPBDGLATMV-UHFFFAOYSA-N 5-[2-(diethylamino)ethoxy]-2-nitrobenzaldehyde Chemical compound CCN(CC)CCOC1=CC=C([N+]([O-])=O)C(C=O)=C1 FUNZYPBDGLATMV-UHFFFAOYSA-N 0.000 description 1
- USLPRYCBDKMZGO-UHFFFAOYSA-N 5-[2-(dimethylamino)ethoxy]-2-nitrobenzaldehyde Chemical compound CN(C)CCOC1=CC=C([N+]([O-])=O)C(C=O)=C1 USLPRYCBDKMZGO-UHFFFAOYSA-N 0.000 description 1
- CIONPRVYNFDTHL-UHFFFAOYSA-N 5-[2-(dimethylamino)ethyl-methylamino]-2-nitrobenzaldehyde Chemical compound CN(C)CCN(C)C1=CC=C([N+]([O-])=O)C(C=O)=C1 CIONPRVYNFDTHL-UHFFFAOYSA-N 0.000 description 1
- FBXHJIQSXYECCM-UHFFFAOYSA-N 5-[2-(dimethylamino)ethyl]-1,3-dimethoxy-10-(1-phenylprop-2-ynoxyimino)indeno[1,2-b]indol-8-ol Chemical compound COC1=CC(OC)=CC(C2=C3C4=CC(O)=CC=C4N2CCN(C)C)=C1C3=NOC(C#C)C1=CC=CC=C1 FBXHJIQSXYECCM-UHFFFAOYSA-N 0.000 description 1
- ORSSDSSTEISWMM-UHFFFAOYSA-N 5-[2-(dimethylamino)ethyl]-8-hydroxy-1,3-dimethoxyindeno[1,2-b]indol-10-one Chemical compound CN(C)CCN1C2=CC=C(O)C=C2C2=C1C(C=C(C=C1OC)OC)=C1C2=O ORSSDSSTEISWMM-UHFFFAOYSA-N 0.000 description 1
- ONUYTYDJSPRVSW-UHFFFAOYSA-N 5-amino-2-nitrobenzaldehyde Chemical compound NC1=CC=C([N+]([O-])=O)C(C=O)=C1 ONUYTYDJSPRVSW-UHFFFAOYSA-N 0.000 description 1
- QIYDTIMMZOUCGL-UHFFFAOYSA-N 5h-furo[3,4-f][1,3]benzodioxol-7-one Chemical compound C1=C2C(=O)OCC2=CC2=C1OCO2 QIYDTIMMZOUCGL-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- FEMVJRNUEUCDBA-UHFFFAOYSA-N 8-[2-(dimethylamino)ethoxy]-1,4-dimethoxy-5h-indeno[1,2-b]indol-10-one;hydrochloride Chemical compound Cl.N1C2=CC=C(OCCN(C)C)C=C2C2=C1C(C(OC)=CC=C1OC)=C1C2=O FEMVJRNUEUCDBA-UHFFFAOYSA-N 0.000 description 1
- PMUHUJCVPVGWMR-UHFFFAOYSA-N 8-[2-(dimethylamino)ethoxy]-2,3-dimethoxy-5h-indeno[1,2-b]indol-10-one;hydrochloride Chemical compound Cl.C1=C(OCCN(C)C)C=C2C(C(=O)C=3C=C(C(=CC=33)OC)OC)=C3NC2=C1 PMUHUJCVPVGWMR-UHFFFAOYSA-N 0.000 description 1
- ICNUAWWNUIGZBP-UHFFFAOYSA-N 8-[2-(dimethylamino)ethoxy]-5h-indeno[1,2-b]indol-10-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C(=O)C2=C1NC1=CC=C(OCCN(C)C)C=C12 ICNUAWWNUIGZBP-UHFFFAOYSA-N 0.000 description 1
- FGAGRGRSELCXHQ-UHFFFAOYSA-N 8-hydroxy-1,3-dimethoxy-5h-indeno[1,2-b]indol-10-one;hydrochloride Chemical compound Cl.N1C2=CC=C(O)C=C2C2=C1C(C=C(C=C1OC)OC)=C1C2=O FGAGRGRSELCXHQ-UHFFFAOYSA-N 0.000 description 1
- XMKLYZWXUVIWDB-UHFFFAOYSA-N 8-hydroxy-2,3-dimethoxy-5h-indeno[1,2-b]indol-10-one;hydrochloride Chemical compound Cl.C1=C(O)C=C2C(C(=O)C=3C=C(C(=CC=33)OC)OC)=C3NC2=C1 XMKLYZWXUVIWDB-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- DTLGNCPQVLQJRC-UHFFFAOYSA-N C1=C2C=CC=CC2=C2C1=C1NC(=O)C=C1C=C2 Chemical class C1=C2C=CC=CC2=C2C1=C1NC(=O)C=C1C=C2 DTLGNCPQVLQJRC-UHFFFAOYSA-N 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- DXOLOIOZDPFDSV-UHFFFAOYSA-N Cl.N1C2=CC=C(OCCN(C)C)C=C2C2=C1C=1C=C(OC)C(OC)=CC=1C2=NOC(C#C)C1=CC=C(F)C=C1 Chemical compound Cl.N1C2=CC=C(OCCN(C)C)C=C2C2=C1C=1C=C(OC)C(OC)=CC=1C2=NOC(C#C)C1=CC=C(F)C=C1 DXOLOIOZDPFDSV-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- IGYUTAVTLZRYIV-PBYGZKADSA-N N'-[(10Z)-2,3-dimethoxy-10-(1-thiophen-2-ylprop-2-ynoxyimino)-5H-indeno[1,2-b]indol-8-yl]-N,N,N'-trimethylethane-1,2-diamine dihydrochloride Chemical compound Cl.Cl.N1C2=CC=C(N(C)CCN(C)C)C=C2C2=C1C=1C=C(OC)C(OC)=CC=1\C2=N\OC(C#C)C1=CC=CS1 IGYUTAVTLZRYIV-PBYGZKADSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- DHEZQYZJFCIQQA-UHFFFAOYSA-N hydron;o-[(4-methoxyphenyl)methyl]hydroxylamine;chloride Chemical compound Cl.COC1=CC=C(CON)C=C1 DHEZQYZJFCIQQA-UHFFFAOYSA-N 0.000 description 1
- LKCAFSOYOMFQSL-UHFFFAOYSA-N hydron;o-[(4-nitrophenyl)methyl]hydroxylamine;chloride Chemical compound Cl.NOCC1=CC=C([N+]([O-])=O)C=C1 LKCAFSOYOMFQSL-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- SPUACDWLOLSOQO-UHFFFAOYSA-M methoxyazanium;chloride Chemical compound [Cl-].CO[NH3+] SPUACDWLOLSOQO-UHFFFAOYSA-M 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- SRQVQLMWUIADDC-UHFFFAOYSA-N o-(1,3-benzodioxol-5-ylmethyl)hydroxylamine;hydrochloride Chemical compound Cl.NOCC1=CC=C2OCOC2=C1 SRQVQLMWUIADDC-UHFFFAOYSA-N 0.000 description 1
- UZOAJSRELVPONZ-UHFFFAOYSA-N o-(1-phenylbut-3-enyl)hydroxylamine;hydrochloride Chemical compound Cl.C=CCC(ON)C1=CC=CC=C1 UZOAJSRELVPONZ-UHFFFAOYSA-N 0.000 description 1
- AGASWYKEXLOTGY-UHFFFAOYSA-N o-(3-phenylprop-2-ynyl)hydroxylamine;hydrochloride Chemical compound Cl.NOCC#CC1=CC=CC=C1 AGASWYKEXLOTGY-UHFFFAOYSA-N 0.000 description 1
- MUDUEUZSAGAOBK-UHFFFAOYSA-N o-(4-methylphenyl)hydroxylamine;hydrochloride Chemical compound Cl.CC1=CC=C(ON)C=C1 MUDUEUZSAGAOBK-UHFFFAOYSA-N 0.000 description 1
- RUGDBRVEODTQSD-UHFFFAOYSA-N o-(naphthalen-1-ylmethyl)hydroxylamine;hydrochloride Chemical compound Cl.C1=CC=C2C(CON)=CC=CC2=C1 RUGDBRVEODTQSD-UHFFFAOYSA-N 0.000 description 1
- HHQRMKABZGABRY-UHFFFAOYSA-N o-(thiophen-2-ylmethyl)hydroxylamine;hydrochloride Chemical compound Cl.NOCC1=CC=CS1 HHQRMKABZGABRY-UHFFFAOYSA-N 0.000 description 1
- UOISMTPJFYEVBW-UHFFFAOYSA-N o-[(2,3,4,5,6-pentafluorophenyl)methyl]hydroxylamine Chemical compound NOCC1=C(F)C(F)=C(F)C(F)=C1F UOISMTPJFYEVBW-UHFFFAOYSA-N 0.000 description 1
- WDIYOALRWSMTRN-UHFFFAOYSA-N o-[(3,4,5-trimethoxyphenyl)methyl]hydroxylamine;hydrochloride Chemical compound Cl.COC1=CC(CON)=CC(OC)=C1OC WDIYOALRWSMTRN-UHFFFAOYSA-N 0.000 description 1
- QMDOJLTWDMPNPQ-UHFFFAOYSA-N o-[(3,5-dimethylphenyl)methyl]hydroxylamine;hydrochloride Chemical compound Cl.CC1=CC(C)=CC(CON)=C1 QMDOJLTWDMPNPQ-UHFFFAOYSA-N 0.000 description 1
- DPDZSUGVUIGDAX-UHFFFAOYSA-N o-[(3-methoxy-4-phenylmethoxyphenyl)methyl]hydroxylamine;hydrochloride Chemical compound Cl.COC1=CC(CON)=CC=C1OCC1=CC=CC=C1 DPDZSUGVUIGDAX-UHFFFAOYSA-N 0.000 description 1
- NZRRAPGOFAFOHD-QRPNPIFTSA-N o-[(3r)-oct-1-yn-3-yl]hydroxylamine;hydrochloride Chemical compound Cl.CCCCC[C@@H](ON)C#C NZRRAPGOFAFOHD-QRPNPIFTSA-N 0.000 description 1
- YZNDOVGYWWHJBB-UHFFFAOYSA-N o-[(4-fluorophenyl)methyl]hydroxylamine;hydrochloride Chemical compound Cl.NOCC1=CC=C(F)C=C1 YZNDOVGYWWHJBB-UHFFFAOYSA-N 0.000 description 1
- OHLAMDIJRIHQQH-UHFFFAOYSA-N o-[(4-phenoxyphenyl)methyl]hydroxylamine;hydrochloride Chemical compound Cl.C1=CC(CON)=CC=C1OC1=CC=CC=C1 OHLAMDIJRIHQQH-UHFFFAOYSA-N 0.000 description 1
- DSBWIXKKLSGJFJ-UHFFFAOYSA-N o-[(4-phenylphenyl)methyl]hydroxylamine;hydrochloride Chemical compound Cl.C1=CC(CON)=CC=C1C1=CC=CC=C1 DSBWIXKKLSGJFJ-UHFFFAOYSA-N 0.000 description 1
- XZNJHYWXUCCQBV-UHFFFAOYSA-N o-[1-(4-fluorophenyl)prop-2-ynyl]hydroxylamine;hydrochloride Chemical compound Cl.NOC(C#C)C1=CC=C(F)C=C1 XZNJHYWXUCCQBV-UHFFFAOYSA-N 0.000 description 1
- XEAXGNOKDYLPHD-UHFFFAOYSA-N o-benzhydrylhydroxylamine;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(ON)C1=CC=CC=C1 XEAXGNOKDYLPHD-UHFFFAOYSA-N 0.000 description 1
- HAMXDHAZNVTEDN-UHFFFAOYSA-N o-but-3-ynylhydroxylamine;hydrochloride Chemical compound Cl.NOCCC#C HAMXDHAZNVTEDN-UHFFFAOYSA-N 0.000 description 1
- NZRRAPGOFAFOHD-UHFFFAOYSA-N o-oct-1-yn-3-ylhydroxylamine;hydrochloride Chemical compound Cl.CCCCCC(ON)C#C NZRRAPGOFAFOHD-UHFFFAOYSA-N 0.000 description 1
- VFZXTKGYOQIIEK-UHFFFAOYSA-N o-pent-1-yn-3-ylhydroxylamine;hydrochloride Chemical compound Cl.CCC(ON)C#C VFZXTKGYOQIIEK-UHFFFAOYSA-N 0.000 description 1
- YUSMKADHMUVMNC-UHFFFAOYSA-N o-penta-1,4-diyn-3-ylhydroxylamine;hydrochloride Chemical compound Cl.NOC(C#C)C#C YUSMKADHMUVMNC-UHFFFAOYSA-N 0.000 description 1
- DBTXKJJSFWZJNS-UHFFFAOYSA-N o-phenylhydroxylamine;hydrochloride Chemical compound Cl.NOC1=CC=CC=C1 DBTXKJJSFWZJNS-UHFFFAOYSA-N 0.000 description 1
- ZBDXGNXNXXPKJI-UHFFFAOYSA-N o-tert-butylhydroxylamine;hydrochloride Chemical compound Cl.CC(C)(C)ON ZBDXGNXNXXPKJI-UHFFFAOYSA-N 0.000 description 1
- IABDFISGZTWKLL-UHFFFAOYSA-N o-tritylhydroxylamine;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(C=1C=CC=CC=1)(ON)C1=CC=CC=C1 IABDFISGZTWKLL-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- JOVOSQBPPZZESK-UHFFFAOYSA-N phenylhydrazine hydrochloride Chemical compound Cl.NNC1=CC=CC=C1 JOVOSQBPPZZESK-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0107718A FR2826009B1 (fr) | 2001-06-13 | 2001-06-13 | Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20022794D0 NO20022794D0 (no) | 2002-06-12 |
| NO20022794L NO20022794L (no) | 2002-12-16 |
| NO322709B1 true NO322709B1 (no) | 2006-11-27 |
Family
ID=8864253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20022794A NO322709B1 (no) | 2001-06-13 | 2002-06-12 | Nye indenoindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6627650B2 (ru) |
| EP (1) | EP1266887B1 (ru) |
| JP (1) | JP3837090B2 (ru) |
| KR (1) | KR100466068B1 (ru) |
| CN (1) | CN1156446C (ru) |
| AR (1) | AR034471A1 (ru) |
| AT (1) | ATE302183T1 (ru) |
| AU (1) | AU781768B2 (ru) |
| BR (1) | BR0202279A (ru) |
| CA (1) | CA2389766C (ru) |
| CZ (1) | CZ20022083A3 (ru) |
| DE (1) | DE60205538T2 (ru) |
| DK (1) | DK1266887T3 (ru) |
| EA (1) | EA004571B1 (ru) |
| ES (1) | ES2247282T3 (ru) |
| FR (1) | FR2826009B1 (ru) |
| HK (1) | HK1052172A1 (ru) |
| HU (1) | HUP0201992A3 (ru) |
| MX (1) | MXPA02005808A (ru) |
| NO (1) | NO322709B1 (ru) |
| NZ (1) | NZ519522A (ru) |
| PL (1) | PL354472A1 (ru) |
| PT (1) | PT1266887E (ru) |
| SI (1) | SI1266887T1 (ru) |
| SK (1) | SK286055B6 (ru) |
| ZA (1) | ZA200204757B (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006047231B4 (de) * | 2006-10-04 | 2009-02-12 | Hemmerling, Hans-Jörg, Dr. | Substituierte Indeno[1,2-b]indolderivate als neue Hemmstoffe der Protein Kinase CK2 und ihre Verwendung als Tumor Therapeutika, Cytostatika und Diagnostika |
| EP3147323B2 (de) | 2015-09-28 | 2022-12-28 | Henkel AG & Co. KGaA | Thermisch expandierbare zusammensetzungen mit polysaccharid |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6256471A (ja) * | 1985-09-05 | 1987-03-12 | Teikoku Hormone Mfg Co Ltd | 含窒素四環式化合物 |
| SE8902274D0 (sv) * | 1989-06-22 | 1989-06-22 | Univ Cincinnati | Indenoidole compounds ii |
| SE8902273D0 (sv) * | 1989-06-22 | 1989-06-22 | Univ Cincinnati | Indenoindole compounds i |
| SE9302431D0 (sv) * | 1993-07-16 | 1993-07-16 | Ab Astra | Use of indenoindole compounds |
| US6069153A (en) * | 1998-05-12 | 2000-05-30 | American Home Products Corporation | Indenoindoles and benzocarbazoles as estrogenic agents |
| FR2821843B1 (fr) * | 2001-03-12 | 2003-05-09 | Servier Lab | Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2001
- 2001-06-13 FR FR0107718A patent/FR2826009B1/fr not_active Expired - Fee Related
-
2002
- 2002-06-11 MX MXPA02005808A patent/MXPA02005808A/es active IP Right Grant
- 2002-06-11 SK SK834-2002A patent/SK286055B6/sk not_active IP Right Cessation
- 2002-06-11 AU AU45903/02A patent/AU781768B2/en not_active Ceased
- 2002-06-12 PT PT02291463T patent/PT1266887E/pt unknown
- 2002-06-12 SI SI200230176T patent/SI1266887T1/sl unknown
- 2002-06-12 NO NO20022794A patent/NO322709B1/no unknown
- 2002-06-12 JP JP2002171000A patent/JP3837090B2/ja not_active Expired - Fee Related
- 2002-06-12 NZ NZ519522A patent/NZ519522A/en unknown
- 2002-06-12 ES ES02291463T patent/ES2247282T3/es not_active Expired - Lifetime
- 2002-06-12 AR ARP020102206A patent/AR034471A1/es not_active Application Discontinuation
- 2002-06-12 AT AT02291463T patent/ATE302183T1/de not_active IP Right Cessation
- 2002-06-12 DE DE60205538T patent/DE60205538T2/de not_active Expired - Fee Related
- 2002-06-12 EP EP02291463A patent/EP1266887B1/fr not_active Expired - Lifetime
- 2002-06-12 KR KR10-2002-0032814A patent/KR100466068B1/ko not_active IP Right Cessation
- 2002-06-12 DK DK02291463T patent/DK1266887T3/da active
- 2002-06-13 CZ CZ20022083A patent/CZ20022083A3/cs unknown
- 2002-06-13 EA EA200200563A patent/EA004571B1/ru not_active IP Right Cessation
- 2002-06-13 PL PL02354472A patent/PL354472A1/xx not_active Application Discontinuation
- 2002-06-13 BR BR0202279-6A patent/BR0202279A/pt not_active IP Right Cessation
- 2002-06-13 CN CNB021213054A patent/CN1156446C/zh not_active Expired - Fee Related
- 2002-06-13 US US10/171,191 patent/US6627650B2/en not_active Expired - Fee Related
- 2002-06-13 HU HU0201992A patent/HUP0201992A3/hu unknown
- 2002-06-13 ZA ZA200204757A patent/ZA200204757B/xx unknown
- 2002-06-13 CA CA002389766A patent/CA2389766C/fr not_active Expired - Fee Related
-
2003
- 2003-04-03 HK HK03102396A patent/HK1052172A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2059305C (en) | Hexa-cyclic compound | |
| US5834476A (en) | Hexa-cyclic compound | |
| CN113248521B (zh) | 一种k-ras g12c抑制剂及其制备方法和应用 | |
| WO2001042247A1 (fr) | Composes heterotricycliques fusionnes, procede de preparation de ces composes et medicaments contenant ces composes | |
| DK2722332T3 (en) | Quinolylpyrrolopyrimidylforbindelse with concentrated ring or salt thereof. | |
| TW201022262A (en) | Novel compounds 515 | |
| WO2018108079A1 (zh) | 多激酶抑制剂化合物、其晶型及用途 | |
| JP2012211085A (ja) | ヘッジホッグシグナル阻害剤 | |
| AU2008261884A1 (en) | Therapeutic pyrazoloquinoline derivatives | |
| NO322709B1 (no) | Nye indenoindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| ANTONY DANISH et al. | Syntheses and characterisation of N, N'-biscarbazolyl azine and N, N'-carbazolyl hydrazine derivatives and their antimicrobial studies | |
| KR20070107092A (ko) | 티에노피리딘 유도체 및 ｈｓｐ90 조정제로서의 이의 용도 | |
| US20060079677A1 (en) | Novel tricyclic azepine derivatives, method for production thereof and pharmaceutical compositions comprising the same | |
| JP2017525734A (ja) | 癌の治療において有用なイソキノリノン誘導体 | |
| US6407115B1 (en) | Hexa-cyclic compound | |
| CN113195450A (zh) | 取代的杂环稠合的γ-咔啉的合成 | |
| Yamuna et al. | Synthesis of thieno-and benzocyclohepta [b] indoles: Gewald reaction and regioselective cycloaddition of acetylenic esters | |
| KR20090020702A (ko) | 다형체 및 방법 | |
| CN112940004B (zh) | 一种杂环化合物及其用途 | |
| WO2015127878A1 (zh) | 稠合吖啶衍生物及其药物组合物、制备方法及应用 | |
| CN116969942A (zh) | 多靶点抗肿瘤活性的吴茱萸次碱衍生物与应用 | |
| NZ794456A (en) | Novel modulators of the 5-hydroxytryptamine receptor 7 and their method of use |